State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University, Changsha 410082, PR China.
Anal Chem. 2012 Nov 6;84(21):9056-64. doi: 10.1021/ac301461s. Epub 2012 Oct 24.
Fluorescent dye-doped silica nanoparticles are increasingly used for in vivo imaging due to their unique biocompatibility and easy surface modification. However, the utility of existing fluorescent dye-doped silica nanoparticles for in vivo imaging is still limited because most studies are focused on doping single near-infrared (NIR) dyes in the silica matrix, which would cause background and crosstalk between the excitation light and the emitting signals due to the small Stokes shift of the traditional NIR dyes. To address this issue, we present a novel large Stokes shifting NIR fluorescent silica nanoparticles (LSS-NFSiNPs) based on the principle of fluorescence resonance energy transfer. Two highly water-soluble dyes, tris(2,2-bipyridyl)dichlororuthenium(II) hexahydrate (RuBpy) and methylene blue (MB), were chose as the model donor-acceptor pair. The LSS-NFSiNPs were prepared by synchronously doping RuBpy and MB in the silica nanoparticles. By optimizing the molar ratio of RuBpy and MB for doping in the silica nanoparticles, the energy transfer from RuBpy to MB occurred in the silica matrix, resulting in a near-infrared fluorescent silica nanoparticles with strong fluorescence and large Stokes shift (>200 nm). As a result, it can effectively help to increase the discrimination of fluorescence signal of interest over other background signals. With a combination of excellent stability, large Stokes shift, and near-infrared spectral properties, this novel LSS-NFSiNPs provides real-time, deep-tissue fluorescent imaging of live animals. More importantly, the LSS-NFSiNPs can also be gradually cleared from the body through the urinary clearance system. We anticipate this design concept can lay a foundation for further development of in vivo optical nanoparticulate contrast toward clinical applications.
荧光染料掺杂二氧化硅纳米粒子由于其独特的生物相容性和易于表面修饰,越来越多地用于体内成像。然而,由于大多数研究都集中在掺杂单一近红外(NIR)染料于二氧化硅基质中,这会由于传统 NIR 染料的小斯托克斯位移而导致激发光和发射信号之间的背景和串扰,因此现有荧光染料掺杂二氧化硅纳米粒子在体内成像中的应用仍然受到限制。为了解决这个问题,我们提出了一种基于荧光共振能量转移原理的新型大斯托克斯位移近红外荧光硅纳米粒子(LSS-NFSiNPs)。两种高水溶性染料,三(2,2-联吡啶)二氯钌(II)六水合物(RuBpy)和亚甲基蓝(MB),被选为模型供体-受体对。LSS-NFSiNPs 通过在二氧化硅纳米粒子中同步掺杂 RuBpy 和 MB 来制备。通过优化 RuBpy 和 MB 在二氧化硅纳米粒子中掺杂的摩尔比,能量从 RuBpy 转移到 MB 发生在二氧化硅基质中,导致具有强荧光和大斯托克斯位移(>200nm)的近红外荧光硅纳米粒子。结果,可以有效地帮助增加对感兴趣的荧光信号的分辨力超过其他背景信号。由于具有出色的稳定性、大斯托克斯位移和近红外光谱特性,这种新型 LSS-NFSiNPs 可以对活体动物进行实时、深层组织荧光成像。更重要的是,LSS-NFSiNPs 还可以通过尿液清除系统逐渐从体内清除。我们预计这种设计概念可以为进一步开发用于临床应用的体内光学纳米颗粒对比奠定基础。